Keith C. Meyer

13.0k total citations · 5 hit papers
142 papers, 8.6k citations indexed

About

Keith C. Meyer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Keith C. Meyer has authored 142 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 53 papers in Surgery and 25 papers in Physiology. Recurrent topics in Keith C. Meyer's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Transplantation: Methods and Outcomes (46 papers) and Medical Imaging and Pathology Studies (13 papers). Keith C. Meyer is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (57 papers), Transplantation: Methods and Outcomes (46 papers) and Medical Imaging and Pathology Studies (13 papers). Keith C. Meyer collaborates with scholars based in United States, Germany and Italy. Keith C. Meyer's co-authors include Ganesh Raghu, Dieter Worlitzsch, Gerd Döring, Martina Ulrich, Robert Tarran, Richard C. Boucher, Scott H. Randell, Ute Schwab, P. Birrer and Tilo Weiß and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Keith C. Meyer

138 papers receiving 8.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

2002 919 citations Dieter Worlitzsch, Robert Tarran et al. Journal of Clinical Investigation profile →
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

2002 778 citations Dieter Worlitzsch, Robert Tarran et al. Journal of Clinical Investigation profile →
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

2012 720 citations Keith C. Meyer, Ganesh Raghu et al. American Journal of Respiratory and Critical Care Medicine profile →
Direct human health risks of increased atmospheric carbon dioxide

2019 398 citations Keith C. Meyer et al. profile →
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

2014 371 citations Keith C. Meyer, Ganesh Raghu et al. European Respiratory Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Keith C. Meyer	4.8k	1.8k	1.6k	1.5k	1.4k	142	8.6k
James R. Yankaskas	6.7k 1.4×	3.5k 1.9×	1.1k 0.7×	1.1k 0.7×	965 0.7×	103	10.8k
Matthias Griese	8.2k 1.7×	2.2k 1.2×	1.9k 1.2×	1.1k 0.7×	1.5k 1.1×	332	11.7k
Chris Ward	5.8k 1.2×	1.9k 1.0×	2.1k 1.3×	1.6k 1.1×	2.7k 2.0×	337	11.4k
David J. Evans	3.0k 0.6×	3.5k 1.9×	1.1k 0.7×	1.6k 1.1×	3.0k 2.2×	249	13.0k
Young Sam Kim	2.6k 0.5×	1.7k 1.0×	1.4k 0.9×	2.4k 1.6×	1.2k 0.9×	430	8.5k
Peter H. Lin	3.9k 0.8×	2.0k 1.1×	3.4k 2.1×	1.1k 0.8×	630 0.5×	320	10.9k
Hiroshi Mukae	3.9k 0.8×	1.5k 0.8×	816 0.5×	2.6k 1.7×	1.2k 0.9×	669	10.6k
Stephen M. Stick	7.2k 1.5×	1.2k 0.6×	767 0.5×	1.2k 0.8×	3.0k 2.2×	280	10.2k
M. Stern	2.1k 0.4×	964 0.5×	1.7k 1.1×	1.4k 0.9×	836 0.6×	220	7.4k
Joseph M. Pilewski	5.7k 1.2×	2.9k 1.6×	3.1k 1.9×	2.5k 1.6×	1.7k 1.2×	309	13.5k

Countries citing papers authored by Keith C. Meyer

Since Specialization

Citations

This map shows the geographic impact of Keith C. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith C. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith C. Meyer more than expected).

Fields of papers citing papers by Keith C. Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith C. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith C. Meyer. The network helps show where Keith C. Meyer may publish in the future.

Co-authorship network of co-authors of Keith C. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Keith C. Meyer. A scholar is included among the top collaborators of Keith C. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith C. Meyer. Keith C. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Meyer, Keith C.. (2024). The Saga of Recombinant Human Pentraxin-2 as a Potential Therapeutic Agent for Pulmonary Fibrosis. 9(1). 2 indexed citations

2.

Meyer, Keith C., et al.. (2018). Lung disease associated with occupational styrene exposure. American Journal of Industrial Medicine. 61(9). 773–779. 19 indexed citations

3.

McCoy, Sara S., Keith C. Meyer, Jeffrey P. Kanne, et al.. (2018). Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study. Therapeutics and Clinical Risk Management. Volume 14. 2171–2181. 21 indexed citations

4.

Oliveira, Nilto C. De, Walker Julliard, Satoru Osaki, et al.. (2016). Lung transplantation for high-risk patients with idiopathic pulmonary fibrosis.. PubMed. 33(3). 235–241. 5 indexed citations

5.

Newton, Chad A., Kiran Batra, José Torrealba, et al.. (2016). Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. European Respiratory Journal. 48(6). 1710–1720. 225 indexed citations

6.

Oliveira, Nilto C. De, Satoru Osaki, James D. Maloney, Richard D. Cornwell, & Keith C. Meyer. (2011). Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation. Interactive Cardiovascular and Thoracic Surgery. 14(3). 263–267. 29 indexed citations

7.

Oliveira, Nilto C. De, Satoru Osaki, James D. Maloney, Richard D. Cornwell, & Keith C. Meyer. (2011). Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system. European Journal of Cardio-Thoracic Surgery. 41(3). 680–685. 10 indexed citations

8.

Spahr, Jonathan E., et al.. (2007). Lung transplantation for cystic fibrosis: Current concepts and one center's experience. Journal of Cystic Fibrosis. 6(5). 334–350. 31 indexed citations

9.

Mosser, Anne G., Rose F. Vrtis, Wai-Ming Lee, et al.. (2005). Quantitative and Qualitative Analysis of Rhinovirus Infection in Bronchial Tissues. American Journal of Respiratory and Critical Care Medicine. 171(6). 645–651. 161 indexed citations

10.

Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 778 indexed citations breakdown →

11.

Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 919 indexed citations breakdown →

12.

Wilkes, David S., Kathleen M. Heidler, Kazuhiro Yasufuku, et al.. (2001). Cell-mediated immunity to collagen V in lung transplant recipients: correlation with collagen V release into BAL fluid. The Journal of Heart and Lung Transplantation. 20(2). 167–167. 16 indexed citations

13.

Meyer, Keith C., David R. Nunley, James H. Dauber, et al.. (2001). Neutrophils, Unopposed Neutrophil Elastase, and Alpha1-Antiprotease Defenses Following Human Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 164(1). 97–102. 44 indexed citations

14.

Viglio, Simona, Paolo Iadarola, Alessandro Lupi, et al.. (2000). MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. European Respiratory Journal. 15(6). 1039–1039. 87 indexed citations

15.

Barker, Alan F., Stanley B. Fiel, Mark H. Gotfried, et al.. (2000). Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 162(2). 481–485. 239 indexed citations

16.

Croix, Claudette M. St., et al.. (1999). Assessment of Nitric Oxide Formation During Exercise. American Journal of Respiratory and Critical Care Medicine. 159(4). 1125–1133. 48 indexed citations

17.

Nunley, David R., James H. Dauber, Aldo Iacono, et al.. (1999). Unopposed Neutrophil Elastase in Bronchoalveolar Lavage from Transplant Recipients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 159(1). 258–261. 17 indexed citations

18.

Meyer, Keith C., et al.. (1997). Regional Variability of Lung Inflammation in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 156(5). 1536–1540. 68 indexed citations

19.

Meyer, Keith C., William B. Ershler, Nancy S. Rosenthal, Xin Lü, & Kimberly Peterson. (1996). Immune Dysregulation in the Aging Human Lung. American Journal of Respiratory and Critical Care Medicine. 153(3). 1072–1079. 133 indexed citations

20.

Meyer, Keith C., et al.. (1991). Priming of Human Alveolar Macrophages and Blood Monocytes for Superoxide Anion Release by Interferons and Lipopolysaccharide. Journal of Interferon Research. 11(5). 283–290. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact